Abstract
The unique physiologic changes of pregnancy put these patients at heightened risk for cardiovascular emergencies. This chapter reviews the management of three prominent and potentially devastating conditions in the pregnant patient: venous thromboembolism, aortic dissection, and peripartum cardiomyopathy (PPCM). The authors examine risk factors, clinical presentation, and specific management strategies for these life-threatening situations. Overlapping symptoms between multiple life-threatening, yet physiologically different, pathologies can cloud diagnosis of cardiovascular emergencies. Furthermore, early symptoms of these emergencies can mirror normal physiologic changes in pregnancy. This chapter seeks to highlight subtle differences in presentation that enable prompt, accurate identification of these potentially catastrophic complications. Management for each condition, with nuanced and specific evaluation of particular pharmaceutical agents and their safety and efficacy in pregnancy, will also be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
James A, The Committee on Practice Bulletins. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol. 2011;118:718–29.
Heit JA, Kobbervig CE, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143(10):697–706.
Kamel H, Navi BB, et al. Risk of thrombotic event after the 6-week postpartum period. N Engl J Med. 2014;370(14):1307–15.
Conti E, Zezza L, et al. Pulmonary embolism in pregnancy. J Thromb Thrombolysis. 2014;37:251–70.
Regitz-Zagrosek V, Lundqvist CB, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32:3147–97.
Neggers YH. Trends in maternal mortality in the United States. Reprod Toxicol. 2016;64:72–6. doi:10.1016/j.reprotox.2016.04.001.
Van de Pol LM, Mairuhu ATA, Tromeur C, et al. Use of clinical prediction rules and D-dimer tests in the diagnostic management of pregnant patients with suspected acute pulmonary embolism. Blood Rev. 2016; doi:10.1016/j.blre.2016.09.003.
Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem. 2005;51:825–30.
Kovac M, Mikovic Z, Rakicevic L, et al. The use of D-dimer with new cutoff can be useful in diagnosis of venous thromboembolism in pregnancy. Eur J Obstet Gynecol Reprod Biol. 2010;148:27–30.
Wang M, Lu SM, Li S, et al. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer. Clin Chim Acta. 2013;425:176–80.
Ercan S, Ozkan S, Yucel N, et al. Establishing reference intervals for D-dimer to trimesters. J Matern Fetal Neonatal Med. 2015;28:938–87.
Parilla BV, Fournogerakis R, et al. Diagnosing pulmonary embolism in pregnancy: are biomarkers and clinical predictive models useful? Am J Perinatol Rep. 2016;6:e160–4.
Chan WS, Chunilal S, Lee A, et al. A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy. Ann Intern Med. 2007;147:165–70.
Sommerkamp SK, Gibson A. Cardiovascular disasters in pregnancy. Emerg Med Clin North Am. 2012;30:949–59.
Leung AN, Bull TM, et al. An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy. Am J Respir Crit Care Med. 2011;184:1200–8.
Chagnon I, Bouraneaux H, et al. Comparison of two clinical prediction rules and implicit assessment among patients with suspected pulmonary embolism. Am J Med. 2002;113:269–75.
O’Connor C, Moriarty J, et al. The application of a clinical risk stratification score may reduce unnecessary investigations for pulmonary embolism in pregnancy. J Matern Fetal Neonatal Med. 2011;24(12):1461–4.
Kline JA, Kabrhel C. Emergency evaluation for pulmonary embolism, part 2: diagnostic approach. J Emerg Med. 2015;49:104–17.
Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med. 2008;359(19):2025–33.
Bates SM, Middeldorp S, et al. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016;41:92–128.
Rajagopalan S, Nwazota N, Chandrasekhar S. Outcomes in pregnant women with acute aortic dissections: a review of the literature from 2003–2013. International Journal of Obstetric Anesthesia. 2014;23:348–56.
Poppas A, Shroff SG, et al. Serial assessment of the cardiovascular system in normal pregnancy: role of arterial compliance and pulsatile arterial load. Circulation. 1997;95:2407–15.
Nolte JE, Rutherford RB, et al. Arterial dissections associated with pregnancy. J Vasc Surg. 1995;21:515–20.
la Chapelle CF, et al. On behalf of the Dutch Maternal Mortality Committee. Maternal mortality attributable to vascular dissection and rupture in the Netherlands: a nationwide confidential enquiry. BJOG. 2012;119:86–93.
Sahni G. Chest pain syndromes in pregnancy. Cardiol Clin. 2012;30:343–67.
Sliwa K, Hilfiker-Kleiner D, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.
Johnson-Coyle L, Jensen L, Sobey A, ACCF AHA. Peripartum cardiomyopathy: review and practice guidelines. Am J Crit Care. 2012;21(2):89–98.
Ntusi N, Mayosi B. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol. 2009;131(2):168–79.
Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation. 2005;111(16):2050–5.
Lampert MB, Lang RM. Peripartum cardiomyopathy. Am Heart J. 1995;130:860–70.
Diao M, Diop IB, et al. Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum. Arch Mal Coeur Vaiss. 2004;97:25–30.
Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens. 1999;12:541.
Sliwa K, Blauwet L, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy; a proof-of-concept pilot study. Circulation. 2010;121:1465–73.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Curtis, L., Tsipis, N. (2017). Cardiovascular Emergencies of Pregnancy. In: Borhart, J. (eds) Emergency Department Management of Obstetric Complications. Springer, Cham. https://doi.org/10.1007/978-3-319-54410-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-54410-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54409-0
Online ISBN: 978-3-319-54410-6
eBook Packages: MedicineMedicine (R0)